The CEHDR Pharmacoepidemiology Lab conducts population-based research on the use and effects of drugs in real-world settings. Our work focuses on the following areas:
- Drug utilization: Drugs must be appropriately prescribed to optimize benefits and reduce adverse effects. We assess prescription patterns and test interventions to improve the quality of drug prescribing.
- Drug effectiveness and safety: The effectiveness and safety of drugs are established in clinical trials before approval for use, but drug effects may vary when used in real-world settings. We evaluate the effectiveness and safety of drugs in real-world settings, with particular interest in populations under-represented in clinical trials.
- Medication adherence: Patient adherence to prescribed medications is critical for optimizing health outcomes. We assess medication adherence patterns and evaluate interventions to improve adherence.
Selected Pharmacoepidemiology Lab Publications
Pan M, Agovi AM, Anikpo IO, … Ojha RP. Effect of 2018 American College of Cardiology/American Heart Association Guideline Change on Statin Prescription for People Living with HIV. Prev Med Rep. 2023 Mar 16;33:102175.
Lu Y, Gehr AW, Anikpo I, … Ojha RP. Cardiotoxicity among socioeconomically marginalized breast cancer patients. Breast Cancer Res Treat. 2022 Oct;195(3):401-411.
Lu Y, Gehr AW, Meadows RJ, … Ojha RP. Timing of adjuvant chemotherapy initiation and mortality among colon cancer patients at a safety-net health system. BMC Cancer. 2022 May 31;22(1):593.
Agovi AM, Anikpo I, Cvitanovich MJ, … Marcus JL. Brief Report: HIV Pre-exposure Prophylaxis Prescribing in an Urban Safety-Net Health System. J Acquir Immune Defic Syndr. 2021 Nov 1;88(3):e17-e21.
Ojha RP, MacDonald BR, Chu TC, … Stewart RA. Comparative effectiveness of 8- and 12-week ledipasvir/sofosbuvir regimens for HCV infection. Antivir Ther. 2018;23(7):585-592.
View more CEHDR publications in PubMed.